Literature DB >> 34776661

Oversized donor heart transplantation-clinical experience with an underestimated problem.

Srikanth Kasturi1, Thiruthani Kumaran1,2, Varun Shetty1, Julius Punnen1, Shashiraj Subramanya3, Bagirath Raghuraman3, Venkat Rao Parachuri1, Devi Prasad Shetty1.   

Abstract

PURPOSE: Heart transplantation is the definitive treatment for end-stage heart failure. With respect to donor-recipient size matching, the problems with undersized heart transplantation have been widely discussed, but there is a paucity of information on oversized transplants due to the presumed advantage of large hearts. We intend to share our center's experience with oversized heart transplantation and its associated problems which would help to expand the knowledge on oversized cardiac allografts.
METHODS: Patients who underwent isolated heart transplantation at our hospital between March 1, 2008, and March 1, 2020, were included. For adults, a donor-recipient predicted heart mass percentage difference exceeding 30% and for children, a donor-recipient weight ratio < 0.8 and > 2.0 was considered a mismatch. We collected data from the in-patient medical records and analyzed the in-hospital outcomes and survival post-transplant among various other parameters.
RESULTS: Out of the 43 patients included in this study, 32 (74.4%) patients received a matched heart and 11 (25.6%) patients received oversized hearts. None of the patients received an undersized heart. The in-hospital mortality rate of oversized transplants was 18.2% whereas that of matched transplants was 9.4% (p = 0.432). The post-operative characteristics and 1-year survival were comparable between the groups. We encountered problems specific to oversizing in 5 of the 11 patients (45.4%) which are discussed.
CONCLUSION: With the liberalization of donor criteria to overcome organ shortage, oversized heart transplantation poses certain unique challenges, which when efficiently managed offers acceptable outcomes. © Indian Association of Cardiovascular-Thoracic Surgeons 2021.

Entities:  

Keywords:  Donor-recipient size matching; Donor-recipient weight ratio; Heart transplantation; Oversized heart transplantation; Predicted heart mass; Pulmonary artery hypertension

Year:  2021        PMID: 34776661      PMCID: PMC8546007          DOI: 10.1007/s12055-021-01200-6

Source DB:  PubMed          Journal:  Indian J Thorac Cardiovasc Surg        ISSN: 0970-9134


  22 in total

1.  Echocardiographic evaluation of cardiac remodeling after oversized heart transplantation in children.

Authors:  J-H Lin; Y S Chen; J-K Wang; M-H Wu; N-K Chou; S-H Chu; S-S Wang; H-C Lue
Journal:  Transplant Proc       Date:  2002-12       Impact factor: 1.066

2.  Size matching in heart transplantation.

Authors:  B Reichart
Journal:  J Heart Lung Transplant       Date:  1992 Jul-Aug       Impact factor: 10.247

3.  The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients.

Authors:  Maria Rosa Costanzo; Anne Dipchand; Randall Starling; Allen Anderson; Michael Chan; Shashank Desai; Savitri Fedson; Patrick Fisher; Gonzalo Gonzales-Stawinski; Luigi Martinelli; David McGiffin; Jon Smith; David Taylor; Bruno Meiser; Steven Webber; David Baran; Michael Carboni; Thomas Dengler; David Feldman; Maria Frigerio; Abdallah Kfoury; Daniel Kim; Jon Kobashigawa; Michael Shullo; Josef Stehlik; Jeffrey Teuteberg; Patricia Uber; Andreas Zuckermann; Sharon Hunt; Michael Burch; Geetha Bhat; Charles Canter; Richard Chinnock; Marisa Crespo-Leiro; Reynolds Delgado; Fabienne Dobbels; Kathleen Grady; W Kao; Jaqueline Lamour; Gareth Parry; Jignesh Patel; Daniela Pini; Jeffrey Towbin; Gene Wolfel; Diego Delgado; Howard Eisen; Lee Goldberg; Jeff Hosenpud; Maryl Johnson; Anne Keogh; Clive Lewis; John O'Connell; Joseph Rogers; Heather Ross; Stuart Russell; Johan Vanhaecke
Journal:  J Heart Lung Transplant       Date:  2010-08       Impact factor: 10.247

4.  Survival Outcomes of Oversized Cardiac Allografts in Pediatric Patients-A Single-Center Experience in Taiwan.

Authors:  M Ting; C-I Tsao; C-H Wang; N-H Chi; S-C Huang; N-K Chou; Y-S Chen; S-S Wang
Journal:  Transplant Proc       Date:  2018-03-21       Impact factor: 1.066

5.  Benefits of the Modified Bicaval Anastomosis Technique for Orthotopic Heart Transplantation From a Size-Mismatched Marginal Donor.

Authors:  Takashi Kakuta; Satsuki Fukushima; Yusuke Shimahara; Shin Yajima; Naonori Kawamoto; Naoki Tadokoro; Norihide Fukushima; Soichiro Kitamura; Junjiro Kobayashi; Tomoyuki Fujita
Journal:  Circ J       Date:  2019-12-05       Impact factor: 2.993

6.  Predicted heart mass is the optimal metric for size match in heart transplantation.

Authors:  Evan P Kransdorf; Michelle M Kittleson; Lillian R Benck; Jignesh K Patel; Joshua S Chung; Fardad Esmailian; Brenda L Kearney; David H Chang; Danny Ramzy; Lawrence S C Czer; Jon A Kobashigawa
Journal:  J Heart Lung Transplant       Date:  2018-09-27       Impact factor: 10.247

7.  Adaptive growth and remodeling of transplanted hearts in children.

Authors:  Eva Maria Delmo Walter; Michael Huebler; Christof Stamm; Vladimir Alexi-Meskishvili; Yuguo Weng; Felix Berger; Roland Hetzer
Journal:  Eur J Cardiothorac Surg       Date:  2011-09-07       Impact factor: 4.191

8.  Effect of oversizing cardiac allografts on survival in pediatric patients with congenital heart disease.

Authors:  Anees J Razzouk; Joyce K Johnston; Ranae L Larsen; Richard E Chinnock; James A Fitts; Leonard L Bailey
Journal:  J Heart Lung Transplant       Date:  2005-02       Impact factor: 10.247

9.  Impact of low donor to recipient weight ratios on cardiac transplantation.

Authors:  Senthil Nathan Jayarajan; Sharven Taghavi; Eugene Komaroff; Abeel A Mangi
Journal:  J Thorac Cardiovasc Surg       Date:  2013-08-01       Impact factor: 5.209

10.  Donor Oversizing Results in Improved Survival in Patients with Left Ventricular Assist Device.

Authors:  Erin M Schumer; Matthew C Black; Michael P Rogers; Jaimin R Trivedi; Emma J Birks; Andrew J Lenneman; Allen Cheng; Mark S Slaughter
Journal:  ASAIO J       Date:  2016 Sep-Oct       Impact factor: 2.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.